Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Medtronic Study Shows Faster Catheter Work

By Drug Discovery Trends Editor | June 22, 2010

MINNEAPOLIS (AP) – Medical device maker Medtronic Inc. said late-stage study data shows two catheters it is seeking approval for in the United States work faster than a traditional approach in helping doctors treat forms of atrial fibrillation, a condition that could trigger a stroke.

The Minneapolis company said its Arctic Front Cardiac CyroAblation Catheter and Pulmonary Vein Ablation Catheter were more than 35 percent faster in achieving pulmonary vein isolation compared to point-by-point focal ablation procedures.

Atrial fibrillation causes the upper chambers of the heart to contract irregularly, potentially triggering a stroke. Pulmonary vein isolation stops the rapid beating of the heart’s upper chambers by blocking conduction pathways that trigger atrial fibrillation. The catheters are inserted through an artery in the groin and then threaded up to the heart.

Spokeswoman Catherine Peloquin said the Medtronic catheters can reduce procedure time and allow doctors to schedule more appointments in a day.

Both catheters are approved in Europe to treat different forms of atrial fibrillation, and both are currently being reviewed by the U.S. Food and Drug Administration.

Date: June 18, 2010
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE